Get the Stockscreener App
3.975
0.89%
0.025
Evolent Health Inc stock is traded at $3.975, with a volume of 1.78M.
It is up +0.89% in the last 24 hours and up +1.14% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
See More
Previous Close:
$3.95
Open:
$3.93
24h Volume:
1.78M
Relative Volume:
0.51
Market Cap:
$444.17M
Revenue:
$2.35B
Net Income/Loss:
$-74.42M
P/E Ratio:
-4.2287
EPS:
-0.94
Net Cash Flow:
$150.93M
1W Performance:
-1.60%
1M Performance:
+1.14%
6M Performance:
-66.20%
1Y Performance:
-66.79%
1-Day Range:
$3.90
$4.035
1-Week Range:
$3.86
$4.07
52-Week Range:
$3.495
$12.98
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
3.98 | 440.82M | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
237.44 | 36.38B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
69.47 | 11.51B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
45.80 | 8.60B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.86 | 7.99B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
40.62 | 7.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-13-25 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Evolent Health (EVH) Analyst Maintains Rating, Lowers Price Targ - GuruFocus
Citizens lowers Evolent Health stock price target on ACA membership concerns - Investing.com UK
Evolent reports inducement award - Medical Buyer
Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 - The Malaysian Reserve
Evolent reports inducement award under NYSE listing rule 303A.08 - marketscreener.com
The Truth About Evolent Health Inc (EVH): Underdog Stock or Next Big Health Tech Flex? - AD HOC NEWS
Is the options market predicting a spike in Evolent Health stock? - MSN
Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025 - Quantisnow
Evolent Health (EVH) sells ACO unit, strengthens balance sheet - MSN
Is the Options Market Predicting a Spike in Evolent Health Stock? - Zacks Investment Research
Evolent Health (EVH) Sells ACO Unit, Strengthens Balance Sheet - Finviz
11 Best Healthcare AI Stocks to Buy Now - Insider Monkey
Evolent Health (EVH) downgraded by Canaccord amid increased near-term uncertainty and ambiguity in Medicare/Medicaid membership - MSN
Energy Moves: Why Evolent Health Inc stock is trending among retail tradersPortfolio Update Summary & Trade Opportunity Analysis Reports - moha.gov.vn
How Evolent Health Inc Class stock compares with tech leaders2025 Short Interest & Daily Entry Point Alerts - Улправда
How Evolent Health Inc. stock reacts to inflationary pressures2025 Earnings Surprises & High Return Trade Guides - ulpravda.ru
Why Evolent Health Inc. stock is trending among retail tradersWeekly Market Outlook & Free Community Consensus Stock Picks - DonanımHaber
Does Evolent Health Inc. stock trade at a discount to peersJuly 2025 Patterns & Long-Term Capital Growth Strategies - Улправда
How Evolent Health Inc Class stock reacts to Fed tighteningJuly 2025 Closing Moves & Trade Opportunity Analysis - DonanımHaber
Can Evolent Health Inc Class stock surprise with quarterly resultsJuly 2025 Levels & Daily Entry Point Trade Alerts - DonanımHaber
Is Evolent Health Inc. stock a dividend growth opportunityJuly 2025 Reactions & Scalable Portfolio Growth Methods - Улправда
EVH (Evolent Health) Debt-to-Asset : 0.44 (As of Sep. 2025) - GuruFocus
Evolent Health (EVH) Downgraded by Canaccord Amid Increased Near-Term Uncertainty and Ambiguity in Medicare/Medicaid Membership - Insider Monkey
Is Evolent Health Inc 9EH a good long term investmentStock Market Trends & These 3 Stocks Could Change Your Portfolio - earlytimes.in
20 Stocks That Will Double in 2026 - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Evolent Health (EVH) and AbSci (ABSI) - The Globe and Mail
Evolent Health (EVH) director files insider report showing no share holdings - Stock Titan
Evolent Health Reports Strong Q3 2025 Results - MSN
3 Healthcare Stocks We Think Twice About - Yahoo Finance
Free cash flow per share of Evolent Health Inc Class A – BER:9EH - TradingView — Track All Markets
How the Narrative Surrounding Evolent Health Is Shifting After New Contracts and Softer Earnings Outlook - Yahoo Finance
(EVH) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Evolent Health Completes Stock Purchase Agreement - TipRanks
Privia Health completes acquisition of ACO business from Evolent Health By Investing.com - Investing.com South Africa
Privia Health completes acquisition of ACO business from Evolent Health - Investing.com
Evolent Health (EVH) subsidiary closes Stock Purchase Agreement with Privia Management - Stock Titan
Evolent Health Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Is Evolent Health Inc Class stock testing key support2025 Institutional Moves & Accurate Entry/Exit Alerts - Newser
Will Evolent Health Inc Class stock justify high valuationProduct Launch & Reliable Price Action Trade Plans - Newser
What market sentiment indicators show for Evolent Health Inc Class stockEarnings Risk Report & Daily Oversold Stock Bounce Ideas - Newser
EVH SEC FilingsEvolent Health Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Can Evolent Health Inc. stock weather global recessionEarnings Risk Summary & Reliable Trade Execution Plans - Newser
How Evolent Health Inc. (9EH) stock expands through international marketsJuly 2025 Setups & Entry Point Confirmation Signals - Newser
Will Evolent Health Inc Class stock outperform foreign stocksEntry Point & Low Risk Entry Point Tips - Newser
Privia Management Company, LLC acquired Evolent Care Partners Holding Company, Inc. from Evolent Health, Inc.. - marketscreener.com
Evolent Health, American Oncology Network Partner to Streamline Cancer Care - MSN
How geopolitical risks impact Evolent Health Inc Class stockPortfolio Gains Report & Verified Stock Trade Ideas - Newser
Evolent Health Appoints Jill Smith to Board - The Globe and Mail
Piper Sandler slashes Evolent Health stock price target to $6 from $18 - Investing.com Canada
Evolent Health (EVH) names new independent director and reiterates Q4 2025 guidance - Stock Titan
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):